Podcast to Practice is the expert-led independent medical educational series aimed at healthcare professionals, brought to you by Springer Health+ IME. Each episode features leading clinical experts in their respective fields, covering a broad range of disease states from the well studied oncology, to lesser known rare diseases. Podcast to Practice discusses latest evidence-based research, clinical guidelines and expert discussions around diagnosis, therapies, and patient management, inspiring healthcare professionals to maximise their learning and make measurable change in their own clinical practice.
Podcast to Practice is a production of Springer Health+ IME, the global independent medical educational provider. More info is available at https://ime.springerhealthplus.com
All content for Springer Health+ IME: Podcast to Practice is the property of Springer Health+ IME and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Podcast to Practice is the expert-led independent medical educational series aimed at healthcare professionals, brought to you by Springer Health+ IME. Each episode features leading clinical experts in their respective fields, covering a broad range of disease states from the well studied oncology, to lesser known rare diseases. Podcast to Practice discusses latest evidence-based research, clinical guidelines and expert discussions around diagnosis, therapies, and patient management, inspiring healthcare professionals to maximise their learning and make measurable change in their own clinical practice.
Podcast to Practice is a production of Springer Health+ IME, the global independent medical educational provider. More info is available at https://ime.springerhealthplus.com
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments | S6E3
Springer Health+ IME: Podcast to Practice
21 minutes
4 months ago
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments | S6E3
Prof. Amer Zeidan and Prof. Courtney D. DiNardo discuss the mechanism of action, efficacy, and safety profiles of novel targeted therapies for IDH1-mutant R/R AML.
Springer Health+ IME: Podcast to Practice
Podcast to Practice is the expert-led independent medical educational series aimed at healthcare professionals, brought to you by Springer Health+ IME. Each episode features leading clinical experts in their respective fields, covering a broad range of disease states from the well studied oncology, to lesser known rare diseases. Podcast to Practice discusses latest evidence-based research, clinical guidelines and expert discussions around diagnosis, therapies, and patient management, inspiring healthcare professionals to maximise their learning and make measurable change in their own clinical practice.
Podcast to Practice is a production of Springer Health+ IME, the global independent medical educational provider. More info is available at https://ime.springerhealthplus.com
